+44 (0)20 8817 5296info@tritrials.com

Resources

Trial oversight in SMB Pharma – Reflections on 6th CQOF

Firstly, I wanted to say what a great event the CQOF was – well attended, well organised, great presentations and great dialogue. Well done Kristen and her team. There were a few more attendees than last year which is always positive, but a very different demographic and feel to the event. The focus on the relationship between trial oversight…

Read More

TRI to Sponsor and Present at 6th Clinical Quality Oversight Forum

Please feel free to come by our booth for a demo of OPRA, the risk-based monitoring platform, and to find out how we can help you kick-start your RBM program. Our CEO, Duncan Hall will be presenting on the following RBM and quality oversight related topic: Identifying Relevant Risk Indicators for Each Stage of the Trial to Optimize Quality…

Read More

European Clinical Insights Press Release

TRI were delighted to take part in such a valuable set of meetings and have just been quoted in OmniComm’s recent press release regarding the event. TRI pride themselves on supporting the growth in uptake and understanding of risk-based monitoring within our industry and as such, events like these provide the perfect platform to understand the needs and challenges…

Read More

TRI complete second round of funding

Raleigh, NC, July 20th 2015 – TRI, the risk-based monitoring company, is very excited to announce the completion of their second round of funding, and the furthering of its partnership with Peter Brummitt and Bev Mehentee, co-founders of Wider Perspectives Ltd. TRI is enjoying ongoing and rapid growth thanks to strong market demand both for OPRA, the risk-based monitoring…

Read More

OPRA, the RBM platform: Autumn demo schedule

Each demo will be a 30 min live presentation which will cover the fundamentals of TRI’s four pillars of risk-based monitoring: Identify, Manage, Mitigate and Report (on site quality risk). Please follow the link to register for any of the demos: OPRA demo registration

Read More

TRI releases OPRA Evolution 4

First – a little bit of background: TRI are committed to ensuring OPRA is the most up to date, usable and fully featured RBM platform available. In order to achieve this we need to do three things. 1 – listen to our customers – what do you like? what do you want to improve? what do you want to…

Read More

Clinical Insight Symposia

TRI will be speak on RBM at the London (June 3rd) and Basel (June 11th) events. Please click the link below to register for any or all of the events. We look forward to seeing you there. Registration

Read More

Why is the funnel plot so important to risk-based monitoring?

Before I dive into some of the detail about funnel plots, I wanted to start by highlighting a few key concepts, driven by risk-based monitoring (RBM) which are likely to come into play, whatever your specific approach to RBM is going to be:   You want to start assessing site quality risk as early in the trial as possible,…

Read More

A monitor’s perspective on RBM

I recently had the pleasure of meeting with a group of monitors and trainers working on a RBM project.  Over the course of the meeting the team were introduced to terms such as risk, mitigation, thresholds, key risk indicators (KRIs), probability, RAG (red, amber, green) status, root cause analysis …  I could see their eyes widening as they were faced…

Read More

Build or Buy RBM Technology?

“We are trying to decide if we will build or buy something for risk-based monitoring”, or some variation of it, is something we hear at nearly every meeting with a prospective customer of TRI’s OPRA. With everything from email to infrastructure to applications frequently being outsourced today, I find it curious that so many companies are interested in making…

Read More

Risk-based monitoring poll #2

Again, we want to say thank you for all those who attended and the very positive feedback we’ve had since the webinar. We asked you where the key challenges in implementing RBM are.  It should be noted that we allowed the respondents pick more than one challenge if they wanted to. The results are shown below: Knowing where to…

Read More

The impact of RBM on sites

1 – There are still a significant proportion of trial sites who are not being informed that there is a risk-based approach being taken to the monitoring of their site. This is an easy issue to remedy and one that will start to build trust immediately. 2 – There is concern from sites that RBM is being used to…

Read More